S9800-01-34-ATTACHMENT A—T22(CAM-17)Metals NIOSH Guide to Chemical Hazards-2007
<br /> AntimonyFormula: CAS#: RTECS* IDLH.
<br /> Sb 7440-36-0 CC4025000 50 mg/nt3 (as Sb)
<br /> Conversion: DOT: 1549 157 (inorganic compounds,n.o.s.);2871 170(powder);
<br /> 3141 157(inorganic liquid compounds,n.o.s.)
<br /> Synonyms/Trade Names:Antimony metal,Antimony powder,Stibium
<br /> Exposure Limits: Measurement Methods
<br /> NIOSH REL':TWA 0.5 mg/m3 (see Table 1):
<br /> OSHA PEL`: TWA 0.5 mg/m3 NIOSH 7301, 7303,
<br /> [`Note: The REL and PEL also apply to other antimony compounds(as Sb).] P&CAM 261 (11-4)
<br /> Physical Description:Silver-white,lustrous,hard,brittle solid;scale-like crystals: OSHA IDI 21,ID125G,I0206
<br /> or a dark-gray, lustrous powder.
<br /> Chemical&Physical Personal Protection/Sanitation Respirator Recommendations
<br /> Properties: (see Table 2): (see Tables 3 and 4):
<br /> MW: 121.8 Skin: Prevent skin contact NIOSH/OSHA
<br /> BP: 2975'F Eyes: Prevent eye contact 5 mgfm3:95XQ/Sa
<br /> Sol: Insoluble Wash skin:When contam 12.5 mg/m3: Sa:Cf/PaprHie
<br /> FI.P: NA Remove:When wet or contam 25 mg/m3: 100F/SaT:Cf/PaprTHle/ScbaF/SaF
<br /> IP: NA Change: Daily 50 mgfm3:Sa:Pd,Pp
<br /> Sp.Or: 6.69 §: Scba F:Pd,Pp/SaF:Pd,Pp AScba
<br /> VP: 0 mmHg(approx) Escape: 100F/ScbaE
<br /> MLT: 1166°F
<br /> UEL: NA
<br /> LEL: NA
<br /> Noncombustible Solid in bulk form, but a moderate explosion hazard in the form of dust when exposed to flame.
<br /> Incompatibilities and Reactivities:Strong oxidizers,acids,halogenated acids
<br /> [Note: Stibine is formed when antimony is exposed to nascent (freshly formed)hydrogen.]
<br /> Exposure Routes,Symptoms,Target Organs(see Table 5): lFirst Aid(see Table 6):
<br /> ER: Inh,Ing,Con Eye: Irr immed
<br /> SY: lait eyes,skin,nose,throat.mouth;cough;dizz; head;nau, Skin: Soap wash immed
<br /> vomit,diarr;stomach cramps;insom;anor;unable to smell properly Breath: Resp support
<br /> TO: Eyes,skin,resp sys,CVS Swallow:Medical attention immed
<br /> Fomtula: CAS#: RTECS#: IDLH:
<br /> As(metal) 7440-38-2(metal) CGO525000(metal) Ca[5 mg/m3(as As)]
<br /> Conversion: DOT: 1558 152(metal); 1562 152 (dust)
<br /> Synonymsfrade Names: Arsenic metal:Arsenia
<br /> Other synonyms vary depending upon the speclflc As compound. [Note:OSHA considers"Inorganic Arsenic'
<br /> to mean cop er acetoarsenite&all inorganic compounds containingarsenic except ARSINE.
<br /> Exposure Limits: Measurement Methods
<br /> NIOSH REL:Ca (see Table 1):
<br /> C 0.002 mg/m3 [15-minute] NIOSH 7300,7301, 7303,
<br /> See Appendix A 9102,7900
<br /> OSHA PEL:[1910.1018]TWA 0.010 mg/m3 OSHA ID106
<br /> Physical Description:Metal:Silver-gray or tin-white.brittle, odorless solid.
<br /> Chemical&Physical Properties: Personal Protection/Sanitation Respirator Recommendations
<br /> MW:74.9 (see Table 2): (see Tables 3 and 4):
<br /> BP:Sublimes Skin: Prevent skin contact NIOSH
<br /> Sol:Insoluble Eyes: Prevent eye contact '1: ScbaF:Pd,Pp/SaF:Pd,Pp:AScba
<br /> FLP:NA Wash skin:When contam/Daily Escape:GmFAg100/ScbaE
<br /> IP:NA Remove:When wet or contam
<br /> Sp.Or:5.73(metal) Change:Daily See Appendix E(page 351)
<br /> VP:0 mmHg(approx) Provide:Eyewash
<br /> MLT: 1135°F(Sublimes) Quick drench
<br /> UEL:NA
<br /> LEL:NA
<br /> Metal:Noncombustible Solid in bulk form,but a slight explosion hazard in the form of dust when exposed to flame.
<br /> Incompatibilities and Reactivities:Strong oxidizers,bromine azide
<br /> [Note: Hydrogen gas can react with inorganic arsenic to form the highly toxic gas arsine.]
<br /> Exposure Routes,Symptoms,Target Organs(see Table 5): First Aid(see Table 6):
<br /> ER:Inh,Abs,Con,Ing Eye:Irr immed
<br /> SY:Ulceration of nasal septum,Berm,GI disturbances,per[neur, Skin:Soap wash immed
<br /> resp irrit.hyperpig of skin,[carc] Breath:Resp support
<br /> TO:Liver,kidneys,skin,lungs,lymphatic sys Dung&lymphatic cancer] Swallow: Medical attention Immed
<br /> L Linden USC SI and Removal,Task Order No.34 Caltrans Contract 06A1895,EFIS 10-1300-0181-0
<br /> Geocon Project No.S9800-01-34 Page A-I of 8 September 2014
<br /> t.
<br />
|